Seol Jae Hee, Song Jinyoung, Kim Soo Jin, Ko Hoon, Na Jae Yoon, Cho Min Jung, Choi Hee Joung, Lee Jue Seong, Oh Kyung Jin, Jung Jo Won, Jung Se Yong
Department of Pediatrics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hepatol Commun. 2024 Nov 15;8(12). doi: 10.1097/HC9.0000000000000580. eCollection 2024 Dec 1.
Despite the development of several imaging modalities for diagnosing Fontan-associated liver disease (FALD), there is no optimal protocol for the follow-up of FALD. We conducted a systematic review and meta-analysis to identify factors related to liver fibrosis using biopsy reports and to identify alternative noninvasive modalities that could better reflect liver histological changes in FALD.
A systematic review and meta-analysis were conducted following the PRISMA guidelines Table S2. We searched Embase, PubMed, and Cochrane databases for studies on FALD, focusing on those assessing clinical factors associated with liver fibrosis severity through liver biopsy and noninvasive imaging techniques.
A total of 42 studies were identified, of which 12 conducted meta-analyses and subgroup analyses of the severity of liver fibrosis using liver biopsies. Liver biopsy results showed a weak positive correlation between Fontan duration and fibrosis severity (R = 0.36). Subgroup analyses revealed significant differences in hemodynamic parameters, such as Fontan pressure, between patients with mild and severe fibrosis. Platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index were significantly associated with fibrosis severity, with severe fibrosis showing lower platelet counts and higher aspartate aminotransferase to platelet ratio index and fibrosis-4 index levels. Noninvasive imaging modalities, particularly magnetic resonance elastography and shear wave elastography, demonstrated strong correlations with biopsy-confirmed fibrosis severity.
This study identifies key clinical factors, and noninvasive modalities accurately reflect liver fibrosis severity in patients with FALD. Clinical factors such as platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index may aid in identifying patients at risk for severe fibrosis. In addition, magnetic resonance elastography and shear wave elastography are promising tools for noninvasive assessment in our study. Further research is needed to refine these diagnostic approaches and improve patient management.
尽管已开发出多种用于诊断Fontan相关肝病(FALD)的成像方式,但尚无针对FALD随访的最佳方案。我们进行了一项系统评价和荟萃分析,以利用活检报告确定与肝纤维化相关的因素,并确定能够更好反映FALD肝脏组织学变化的替代性非侵入性检查方法。
按照PRISMA指南(表S2)进行系统评价和荟萃分析。我们在Embase、PubMed和Cochrane数据库中检索关于FALD的研究,重点关注那些通过肝活检和非侵入性成像技术评估与肝纤维化严重程度相关的临床因素的研究。
共识别出42项研究,其中12项使用肝活检对肝纤维化严重程度进行了荟萃分析和亚组分析。肝活检结果显示Fontan手术持续时间与纤维化严重程度之间呈弱正相关(R = 0.36)。亚组分析显示,轻度和重度纤维化患者在血流动力学参数(如Fontan压力)方面存在显著差异。血小板计数、天冬氨酸转氨酶与血小板比值指数以及Fibrosis-4指数与纤维化严重程度显著相关,重度纤维化患者的血小板计数较低,天冬氨酸转氨酶与血小板比值指数和Fibrosis-4指数水平较高。非侵入性成像方式,尤其是磁共振弹性成像和剪切波弹性成像,与活检证实的纤维化严重程度显示出强相关性。
本研究确定了关键临床因素,且非侵入性检查方法能准确反映FALD患者的肝纤维化严重程度。血小板计数、天冬氨酸转氨酶与血小板比值指数以及Fibrosis-4指数等临床因素可能有助于识别严重纤维化风险患者。此外,在我们的研究中,磁共振弹性成像和剪切波弹性成像是有前景的非侵入性评估工具。需要进一步研究以完善这些诊断方法并改善患者管理。